{
  "schema_version": "0.4",
  "ir_kind": "core",
  "metadata": {
    "title": "Protocol",
    "source": {
      "type": "paper_pdf",
      "id": "s41596-025-01197-x.pdf"
    }
  },
  "resources": {
    "materials": [
      {
        "id": "m_dorsomorphin",
        "name": "dorsomorphin"
      },
      {
        "id": "m_sb431542",
        "name": "SB-431542"
      },
      {
        "id": "m_neurobasal_media",
        "name": "neurobasal media"
      },
      {
        "id": "m_b27_supplement",
        "name": "vitamin A-containing B27 supplement"
      },
      {
        "id": "m_fgf2",
        "name": "FGF2"
      },
      {
        "id": "m_egf",
        "name": "EGF"
      }
    ],
    "containers": [],
    "equipment": [],
    "samples": [
      {
        "id": "sample1",
        "type": "reaction"
      }
    ],
    "data": []
  },
  "protocol": {
    "steps": [
      {
        "id": "s1",
        "op": "allocate",
        "params": {
          "allocate_kind": "sample"
        },
        "outputs": [],
        "inputs": []
      },
      {
        "id": "s2",
        "op": "annotate",
        "params": {
          "note": "Neural induction uses dual-SMAD inhibitors dorsomorphin (4 μM) and SB-431542 (10 μM) in neurobasal media with vitamin A-containing B27 supplement, plus FGF2 (10 ng/mL) and EGF (10 ng/mL)."
        },
        "inputs": [],
        "outputs": []
      },
      {
        "id": "s3",
        "op": "annotate",
        "params": {
          "note": "Neural rosettes (NRs) are self-organized 3D structures of neuroepithelial and radial glial cells around a central lumen; emergence observed at 6–8 days post EGF/FGF2 treatment."
        },
        "inputs": [],
        "outputs": []
      }
    ],
    "start_step_id": "s1",
    "edges": [
      {
        "from": "s1",
        "to": "s2"
      },
      {
        "from": "s2",
        "to": "s3"
      }
    ],
    "detail_level": 0
  }
}